Candida krusei -: a serious complication in patients with hematological malignancies:: successful treatment with caspofungin

被引：8

作者：

Conen, A. ^{[1
]}

Weisser, M. ^{[2
]}

Joerg, C. Orasch ^{[1
]}

Battegay, M. ^{[1
]}

Trampuz, A. ^{[1
]}

Frei, R. ^{[3
]}

Christen, S.

Heim, D.

Gratwohl, A.

Flueckiger, U. ^{[1
]}

机构：

[1] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, CH-4031 Basel, Switzerland

[2] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland

[3] Univ Basel Hosp, Microbiol Lab, CH-4031 Basel, Switzerland

来源：

TRANSPLANT INFECTIOUS DISEASE | 2008年 / 10卷 / 01期

关键词：

C; krusei; hematological malignancies; neutropenia; caspofungin; EMPIRICAL ANTIFUNGAL THERAPY; BONE-MARROW TRANSPLANTATION; LIPOSOMAL AMPHOTERICIN-B; INVASIVE CANDIDIASIS; FUNGAL-INFECTIONS; PERSISTENT FEVER; CANCER-PATIENTS; FLUCONAZOLE; NEUTROPENIA; FUNGEMIA;

D O I：

10.1111/j.1399-3062.2007.00238.x

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

Candida krusei infections are serious complications in neutropenic patients with hematological malignancies. We report the successful treatment of C. krusei infection with caspofungin in 3 allogeneic hematopoietic stem cell transplant recipients and 1 patient with induction chemotherapy for acute myeloid leukemia.

引用

页码：66 / 70

页数：5

共 24 条

[1]

Candida krusei fungemia -: An escalating serious infection in immunocompromised patients [J].

Abbas, J ;

Bodey, GP ;

Hanna, HA ;

Mardani, M ;

Girgawy, E ;

Abi-Said, D ;

Whimbey, E ;

Hachem, R ;

Raad, I .

ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (17) :2659-2664

[2]

BERGER C, 1988, SCHWEIZ MED WSCHR, V118, P37

[3]

Invasive candidiasis in cancer patients: observations from a randomized clinical trial [J].

DiNubile, MJ ;

Hille, D ;

Sable, CA ;

Kartsonis, NA .

JOURNAL OF INFECTION, 2005, 50 (05) :443-449

[4]

Candida krusei fungemia in an unrelated allogeneic hematopoietic stem cell transplant patient successfully treated with Caspofungin [J].

Fanci, R ;

Guidi, S ;

Bonolis, M ;

Bosi, A .

BONE MARROW TRANSPLANTATION, 2005, 35 (12) :1215-1216

[5]

Fluckiger U, 2006, SWISS MED WKLY, V136, P447

[6]

Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation [J].

Girmenia, C ;

Moleti, ML ;

Micozzi, A ;

Iori, AP ;

Barberi, W ;

Foà, R ;

Martino, P .

JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) :5395-5396

[7]

GOLDMAN M, 1993, MEDICINE, V72, P143, DOI 10.1097/00005792-199372030-00002

[8]

A CONTROLLED TRIAL OF FLUCONAZOLE TO PREVENT FUNGAL-INFECTIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].

GOODMAN, JL ;

WINSTON, DJ ;

GREENFIELD, RA ;

CHANDRASEKAR, PH ;

FOX, B ;

KAIZER, H ;

SHADDUCK, RK ;

SHEA, TC ;

STIFF, P ;

FRIEDMAN, DJ ;

POWDERLY, WG ;

SILBER, JL ;

HOROWITZ, H ;

LICHTIN, A ;

WOLFF, SN ;

MANGAN, KF ;

SILVER, SM ;

WEISDORF, D ;

HO, WG ;

GILBERT, G ;

BUELL, D .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :845-851

[9]

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy [J].

Hakki, Morgan ;

Staab, Janet F. ;

Marr, Meren A. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (07) :2522-2524

[10]

HANNA HA, 2005, M989 ICCAC, pM989

← 1 2 3 →